Households that earn the median annual income would need to spend an average of 7.3% of their earnings to pay for 2 mg of Ozempic.

However, the same eHealth survey revealed that nearly nine in 10 are satisfied with their own insurance.

The survey also noted that 34% of firms require lifestyle or clinical support programs in order for employees to receive GLP-1 agonists for weight loss.

While employers make decisions about covering weight loss drugs, it's crucial they avoid doing so in a vacuum.